Seroprevalence of <i>Trypanosoma cruzi</i> infection among at‐risk blood donors in Japan

Abstract

Seroprevalence of T. cruzi was 0.017% among at-risk donors in Japan. Transfusion-transmitted infection of Chagas disease has not been confirmed to date. Screening for T. cruzi antibodies by targeting at-risk donors is an appropriate strategy for ensuring blood safety in Japan.